The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

This week the U.S. Supreme Court eliminated drug consumers rights to sue generic drug manufacturers. In reviewing cases brought by consumers of the anti-nausea drug Reglan which is generically sold as Metoclopromide the U.S. Supreme Court removed consumers rights to their day in court. The Court has recently rendered a number of opinions that restrict citizens rights to have case heard in court. The pro business court also shielded Walmart from having to defend a class action lawsuit brought by women alleging that they were paid less and promoted less because of their gender.

These decisions are unfortunate because they remove any incentive for large corporations to look out for the safety of drug consumers in the Reglan case and remove incentives to be vigilant against gender discrimination in the Walmart case.

The Metaclopromide- Reglan case is surprisingly illogical because consumers have a right to have their day in court if they take a brand name drug but not if they have received a generic equivalent of the same drug. The court even acknowledged in its opinion that this result was illogical. The dissenting opinion by Justice Sotomayor pointed out that this result was "absurd".

Both of these decisions stem, in my opinion, from the conservative court’s philosophy that business should not be burdened by have to have a jury consider the fairness of thier conduct towards citizens. These decisions did not decide whether the corporations had done wrong or not. The decisions ruled that the consumers and employees did not have a right to even have their cases heard in court at all.

Comments for this article are closed.